BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Fuji
Colorcon
Julphar
Teva
McKesson
AstraZeneca
Deloitte
Harvard Business School
Argus Health

Generated: January 18, 2018

DrugPatentWatch Database Preview

FEXOFENADINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Fexofenadine Hydrochloride, and when can generic versions of Fexofenadine Hydrochloride launch?

Fexofenadine Hydrochloride is a drug marketed by Barr, Actavis Mid Atlantic, Dr Reddys Labs Ltd, Mylan, Teva, Aurolife Pharma Llc, Hetero Labs Ltd V, Sciegen Pharms Inc, Sun Pharm Inds, Wockhardt Ltd, Aurobindo Pharma Ltd, Impax Pharms, and Sun Pharma Global. and is included in seventeen NDAs.

The generic ingredient in FEXOFENADINE HYDROCHLORIDE is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are twenty-three drug master file entries for this compound. Seventeen suppliers are listed for this compound. There are five tentative approvals for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.
Drug patent expirations by year for FEXOFENADINE HYDROCHLORIDE
Pharmacology for FEXOFENADINE HYDROCHLORIDE

US Patents and Regulatory Information for FEXOFENADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sciegen Pharms Inc FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 204507-004 Sep 16, 2015 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE fexofenadine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 076236-001 Apr 14, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 076447-007 Apr 13, 2011 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 076447-008 Apr 13, 2011 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Ltd FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE fexofenadine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 076667-001 Nov 18, 2014 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt Ltd FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 079112-004 Feb 8, 2012 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr FEXOFENADINE HYDROCHLORIDE fexofenadine hydrochloride CAPSULE;ORAL 076169-001 Jul 13, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Ltd FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 076502-008 Apr 12, 2011 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sciegen Pharms Inc FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 204507-003 Sep 16, 2015 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 077081-007 Jul 21, 2011 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Johnson and Johnson
Citi
Daiichi Sankyo
Novartis
Medtronic
Boehringer Ingelheim
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot